02.12.2018
- The US Food and Drug Administration (FDA) has granted pediatric exclusivity for Pfizer’s Lyrica, extending its US exclusive rights until Jun. 30, 2019. As the patent was due to...
19.11.2018
- Pfizer has lost a long-running court battle in the UK after the country’s Supreme Court ruled against the drugmaker in a case relating to Lyrica (pregabalin), which was originally...
17.10.2016
- Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...
